Clinical Trials Logo

Clinical Trial Summary

This study aims to compare clinical outcomes (informed choice and genetic counselling outcomes) and cost (provider and patient time, travel, and telehealth platform) between telegenetics and in-person genetic counselling.


Clinical Trial Description

This study will compare the patient-reported outcomes of telegenetics with in-person consultations for participants considering germline testing for HBOC or Lynch syndrome. It will clarify if telegenetics is a feasible and non-inferior alternative to in-person cancer genetic counselling. Participant responses are important stakeholder views to guide the design of telegenetics to become a mainstream service delivery model welcomed by patients. It aims to recruit 150 prospective consecutive patients attending genetic counselling for Hereditary Breast and Ovarian Cancer (HBOC) and Lynch Syndrome in Clinical Genetic Services (CGS) at National Cancer Centre Singapore (NCCS). Upon completion of the genetic consultation appointments, patients will be completing a series of questions evaluating cognitive and psychosocial outcomes either via hardcopy in-person or online internet-facing questionnaire. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04738708
Study type Observational
Source National Cancer Centre, Singapore
Contact Ryan Tan
Phone +65 6436 8000
Email ryan.shea.tan.y.c@singhealth.com.sg
Status Recruiting
Phase
Start date February 1, 2021
Completion date November 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02543905 - The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment